Kari Riina
Optometrist · Fishers, INNPI 1043375892
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $306,458 of the $307,612 with a category attached, or 99.6%. Zimmer Biomet accounts for 99.6% of it on its own, with 10 other manufacturers making up the rest. Among optometrist clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 65 payments — averaging $4732.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Zimmer Biomet$306K
- Alcon$346
- Johnson & Johnson Vision Care, Inc.$240
- Coopervision Inc.$197
- Bausch & Lomb Americas Inc.$111
- Dompe US, Inc.$56
- plus $204 from 5 others
What the payments were for
- Royalty or licence$306,458100%
- Food & beverage$1,1540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Zimmer Biomet | 24 | $306,458 |
| Alcon | 13 | $346 |
| Johnson & Johnson Vision Care, Inc. | 11 | $240 |
| Coopervision Inc. | 4 | $197 |
| Bausch & Lomb Americas Inc. | 5 | $111 |
| Dompe US, Inc. | 2 | $56 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $54 |
| AbbVie | 2 | $43 |
| Lombart Brothers, Inc. | 1 | $41 |
| Rxsight Inc | 1 | $39 |
| Oyster Point Pharma, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STERNALOCK 360 SYSTEM$212,746
- SternaLock 360$87,027
- Zyston Interbody$6,685
- Multiple Brands Contact Lens$137
- TOTAL30$127
How this compares
$307,612 in reported general payments places this provider in the 95th percentile of 1,318 optometrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 22 | $246 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Fishers
- Kevin SmithFishers$36K
- Mark RoarkFishers$6K
- Brian FiddlerFishers$6K
- Damon DierkerIndianapolis$707K
- Jason JedlickaBloomington$456K
- Rhonda RobinsonIndianapolis$205K
- John CzajaMerrillville$189K
- Peter KollbaumBloomington$60K
- Ryan GustusBluffton$48K
- Steve VargoHighland$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.